Hepatotoxicity is a term used to describe those instances in which a medication or chemical substance has caused injury to the liver.  

A number of drugs can cause liver toxicity. The symptoms of hepatotoxicity (liver damage) can be mild and can escape notice. It can also lead to permanent injury and death. Therefore, it is important to detect hepatotoxicity in its early stages so that steps can be taken to arrest its development and allow the liver to heal.

The symptoms of drug induced hepatitis are similar to that of infectious hepatitis. Patient may suffer from any of the following symptoms :

• General malaise (feeling unwell)
• Anorexia (loss of appetite)
• Nausea and vomiting
• Yellow skin and eyes
• Itching, skin rash
• Diarrhoea (watery and severe)
• Increased or decreased frequency of urination
• Unusual tiredness or weakness
• Aching joints

Toxi-Gard Capsules :

Clinically Proven Hepatoprotective Plant Based Formulations Developed by

DALMIA CENTRE FOR RESEARCH & DEVELOPMENT

• Protects liver from further damage.
• Encourages normal functioning of liver.
• Controls inflammation of liver and makes patient symptom free.
• Corrects impaired levels of liver enzymes.

CLINICAL TRIALS

A randomised double blind placebo controlled study of efficacy and safety of DCBT 8901 (Toxi-Gard) in the treatment of hepatitis – exhibits hepatoprotective and anti-inflammatory activities.

COMPOSITION

Each capsule contains :

Azadirachta indica (Nimba)              32.00 mg

Eclipta Alba (Bhringraja)                  50.00 mg

Phyllanthus Niruri (Bhonyamalaki)    50.00 mg

DOSAGE :  In severe cases 5 Capsules a day ( 2-1-2) after food or as directed by the physician.

INDICATION : Protection to liver damage and as adjuvant therapy with psychotropic drugs.

AVAILABILITY : Pack of 3 Strips x 10 Capsules each